Basic info
Industry
pharmaceutical manufacturing
Sectors
ALK positive lung cancer
pharmaceutics
bio-pharmaceutics
ALK+ NSCLC
Oncology
Clinical Trials
cancer research
research
lung cancer
cancer therapy
kinase inhibitors
ensartinib
clinical trials
ALK inhibitor
bio-pharma
hematology
Health Care
clinical research
investigational agents
Therapeutics
clinical studies
Medical
cancer
pharma
oncology research
Date founded
2006
Funding rounds raised
Total raised
$20M
from 1 investors over 1 rounds
X
Xcovery raised $20M on October 29, 2014
Investors: Betta Pharmaceuticals Co., Ltd.